| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 676 |
| 1 | FINGOLIMOD HYDROCHLORIDE | 117 |
| 2 | OFATUMUMAB | 112 |
| 3 | OCRELIZUMAB | 105 |
| 4 | FINGOLIMOD | 97 |
| 5 | SIPONIMOD | 77 |
| 6 | GLATIRAMER ACETATE | 63 |
| 7 | TERIFLUNOMIDE | 55 |
| 8 | ERGOCALCIFEROL | 47 |
| 9 | INTERFERON BETA-1A | 44 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COLLOIDAL OATMEAL 1% | 1 | 0.0714 |
| 1 | FINGOLIMOD HYDROCHLORIDE | 117 | 0.0230 |
| 2 | SIPONIMOD | 77 | 0.0086 |
| 3 | FINGOLIMOD HCL | 676 | 0.0078 |
| 4 | GLATIRAMER ACETATE INJECTION | 24 | 0.0051 |
| 5 | NATALIZUMAB-SZTN | 1 | 0.0042 |
| 6 | OFATUMUMAB | 112 | 0.0033 |
| 7 | INFLUENZA A VIRUS, INFLUENZA B VIRUS, HISTAMINUM HYDROCHLORICUM, ACONITUM NAP., ARALIA QUINQUEFOLIA, ARSENICUM ALB., BAPTISIA, BRYONIA, CINCHONA, EUPATORIUM PERF., GELSEMIUM, IPECAC., KALI CARB., NUX VOM., PHOSPHORUS, RHUS TOXICODENDRON, ECHINACEA | 1 | 0.0029 |
| 8 | CARMUSTINE | 9 | 0.0019 |
| 9 | OCRELIZUMAB | 105 | 0.0017 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 170 | 0.0123 |
| 1 | CD19-directed Cytolytic Antibody [EPC] | 2 | 0.0023 |
| 2 | Provitamin D2 Compound [EPC] | 47 | 0.0016 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 25 | 0.0013 |
| 4 | Pyrimidine Synthesis Inhibitor [EPC] | 55 | 0.0012 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 232 | 0.0007 |
| 6 | Integrin Receptor Antagonist [EPC] | 45 | 0.0005 |
| 7 | Influenza A M2 Protein Inhibitor [EPC] | 8 | 0.0005 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 29 | 0.0003 |
| 9 | Potassium Channel Blocker [EPC] | 21 | 0.0003 |